Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bentley Pharmaceuticals, Inc.
Pharmaceutical company re-elects 2 directors, approves plan of equity incentives
June 22nd, 2005
Bentley Pharmaceuticals, Inc. (BNT), a specialty pharmaceutical company focused on advanced drug delivery technologies, announced that stockholders at its annual meeting re-elected 2 members to 3-year terms on the board of directors, maintaining the size of the board at 6 directors. Those re-elected to the Board are Miguel Fernandez, former president of the international division of Carter-Wallace, Inc., and James R. Murphy, who was president of Bentley since September 1994 and chairman of the board since June 1995. Also at the meeting, stockholders approved a plan that provides flexibility to the board and compensation committee to issue...
Source: Physician Law Weekly (2005-06-22)
|
